XML 31 R52.htm IDEA: XBRL DOCUMENT v2.4.1.9
Long-Term Debt (Details 2) (USD $)
12 Months Ended 1 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Jan. 31, 2013
Apr. 30, 2014
Debt disclosures          
Proceeds from issuances of note payable, net of debt issuance costs $ 434,677,000us-gaap_ProceedsFromDebtNetOfIssuanceCosts $ 281,622,000us-gaap_ProceedsFromDebtNetOfIssuanceCosts $ (441,000)us-gaap_ProceedsFromDebtNetOfIssuanceCosts    
Interest amount added to principal balance 20,527,000us-gaap_InterestCostsCapitalized 0us-gaap_InterestCostsCapitalized 0us-gaap_InterestCostsCapitalized    
Convertible Subordinated Notes Due 2023          
Debt disclosures          
Loan amount       287,500,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= thrx_Percent2.125ConvertibleDebtMember
 
Proceeds from issuances of note payable, net of debt issuance costs       281,200,000us-gaap_ProceedsFromDebtNetOfIssuanceCosts
/ us-gaap_LongtermDebtTypeAxis
= thrx_Percent2.125ConvertibleDebtMember
 
Interest rate (as a percent) 2.125%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= thrx_Percent2.125ConvertibleDebtMember
       
9% fixed rate term notes due 2029 | GSK          
Debt disclosures          
Loan amount         450,000,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= thrx_Percent9FixedRateTermNotesDue2029Member
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= thrx_GSKMember
Proceeds from issuances of note payable, net of debt issuance costs         434,700,000us-gaap_ProceedsFromDebtNetOfIssuanceCosts
/ us-gaap_LongtermDebtTypeAxis
= thrx_Percent9FixedRateTermNotesDue2029Member
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= thrx_GSKMember
Interest rate (as a percent)         9.00%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= thrx_Percent9FixedRateTermNotesDue2029Member
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= thrx_GSKMember
Percentage of royalties from global net sales         40.00%thrx_PercentageOfRoyaltiesFromGlobalNetSales
/ us-gaap_LongtermDebtTypeAxis
= thrx_Percent9FixedRateTermNotesDue2029Member
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= thrx_GSKMember
Interest amount added to principal balance 20,500,000us-gaap_InterestCostsCapitalized
/ us-gaap_LongtermDebtTypeAxis
= thrx_Percent9FixedRateTermNotesDue2029Member
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= thrx_GSKMember
       
Reserve account for covering remaining milestone payments as a percentage of future milestone payments         40.00%thrx_ReserveAccountForCoveringRemainingMilestonePaymentsAsPercentageOfFutureMilestonePayments
/ us-gaap_LongtermDebtTypeAxis
= thrx_Percent9FixedRateTermNotesDue2029Member
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= thrx_GSKMember
Transaction costs         15,300,000us-gaap_UnamortizedDebtIssuanceExpense
/ us-gaap_LongtermDebtTypeAxis
= thrx_Percent9FixedRateTermNotesDue2029Member
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= thrx_GSKMember
9% fixed rate term notes due 2029 | GSK | Milestone Reserve Account          
Debt disclosures          
Balance of segregated bank account classified as current restricted cash         $ 32,000,000us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue
/ us-gaap_LongtermDebtTypeAxis
= thrx_Percent9FixedRateTermNotesDue2029Member
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= thrx_GSKMember
/ us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis
= thrx_MilestoneReserveAccountMember